Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 712, Issue 1-2, 1998, Pages 129-143

  Van Asperen, Judith ^a   Van Tellingen, Olaf ^a   Beijnen, Jos H ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

7 Deoxydoxorubicinolone; 7 Deoxydoxorubicinone; Doxorubicin; Doxorubicinol

Indexed keywords

7 DEOXYADRIAMYCINONE; 7 DEOXYDOXORUBICINOLONE; DAUNORUBICIN; DOXORUBICIN; DOXORUBICIN DERIVATIVE; DOXORUBICINOL; DRUG METABOLITE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALIBRATION; DRUG DETERMINATION; DRUG SCREENING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BILE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; FECES; FEMALE; HUMANS; MALE; MICE; NAPHTHACENES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0032493793     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(98)00165-0     Document Type: Article

References (20)

1. Arcamone F., Cassinelli G., Fantini G., Grein A., Orezzi P., Pol C., Spalla C. Biotechnol. Bioeng. 11:1969;1101.
2. Booser D.J., Hortobagyi G.N. Drugs. 47:1994;223.
3. Kartner N., Shales M., Riordan J.R., Ling V. Cancer Res. 43:1983;4413.
4. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Cell. 77:1994;491.
5. van Asperen J., Schinkel A.H., Beijnen J.H., Nooijen W.J., Borst P., van Tellingen O. J. Natl. Cancer Inst. 88:1996;994.
6. Sparreboom A., van Asperen J., Mayer U., Schinkel A.H., Smit J.W., Meijer D.K.F., Borst P., Nooijen W.J., Beijnen J.H., van Tellingen O. Proc. Natl. Acad. Sci. USA. 94:1997;2031.
7. Lown J.W. Pharmacol. Ther. 60:1993;185.
8. Arcamone F., Lazatti M., Vicario G.P., Zini G. Cancer Chemother. Pharmacol. 12:1984;157.
9. Schwartz H.S. Biochem. Med. 7:1973;396.
10. Formelli F., Pollini C., Casazza A.M., di Marco A., Mariani A. Cancer Chemother. Pharmacol. 5:1981;139.
11. Yesair D.W., Schwartzbach E., Shuck D., Denine E.P., Asbell M.A. Cancer Res. 32:1972;1177.
12. Baurain R., Deprez-de Campeneere D., Trouet A. Cancer Chemother. Pharmacol. 2:1979;11.
13. Shinozawa S., Mimaki Y., Araki Y. J. Chromatogr. 196:1980;463.
14. Camaggi C.M., Comparsi R., Strocchi E., Testoni F., Pannuti F. Cancer Chemother. Pharmacol. 21:1988;221.
15. Maessen P.A., Pinedo H.M., Mross K.B., van der Vijgh W.J.F. J. Chromatogr. 424:1988;103.
16. Beijnen J.H., Meenhorst P.L., van Gijn R., Fromme M., Rosing H., Underberg W.J.M. J. Pharm. Biomed. Anal. 9:1991;995.
17. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309.
18. Iguchi H., Tone H., Ishikura T., Takeuchi T., Umezawa H. Cancer Chemother. Pharmacol. 15:1985;132.
19. van der Vijgh W.J.F., Maessen P.A., Pinedo H.M. Cancer Chemother. Pharmacol. 26:1990;9.
20. Cummings J., Merry S., Willmott N. Eur. J. Cancer Clin. Oncol. 22:1986;451.